- Title
- Ensuring access to safe, effective, and affordable cannabis-based medicines
- Creator
- Martin, Jennifer H.; Hall, Wayne; Fitzcharles, Mary-Ann; Borgelt, Laura; Crippa, Jose
- Relation
- British Journal of Clinical Pharmacology Vol. 86, Issue 4, p. 630-634
- Publisher Link
- http://dx.doi.org/10.1111/bcp.14242
- Publisher
- Wiley-Blackwell
- Resource Type
- journal article
- Date
- 2020
- Description
- Over the past decade, patients, families, and medical cannabis advocates have campaigned in many countries to allow patients to use cannabis preparations to treat the symptoms of serious illnesses that have not responded to conventional treatment. Ideally, any medical use of a cannabinoid would involve practitioners prescribing an approved medicine produced to standards of Good Manufacturing Practice (GMP), the safety and effectiveness of which had been assessed in clinical trials. The prescriber would be fully acquainted with the patient's medical history and well-informed about the safety and efficacy of cannabinoid medicines and know the most appropriate formulations and dosages to use and how they should be used in combination with other medicines being used to treat the patient's condition. Current medical use of cannabinoids falls short of these expectations and regulations.
- Subject
- medical cannabis; patients; practitioners; medical conditions
- Identifier
- http://hdl.handle.net/1959.13/1462015
- Identifier
- uon:46364
- Identifier
- ISSN:0306-5251
- Language
- eng
- Reviewed
- Hits: 1305
- Visitors: 1303
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|